FDAnews
www.fdanews.com/articles/113722-analysts-say-exact-deal-not-vital-to-sequenom

Analysts Say Exact Deal Not Vital to Sequenom

January 13, 2009
Cancer test maker Exact Sciences Corp. rebuffed a buyout bid from genetic analysis product maker Sequenom Inc., and analysts said the purchase isn’t necessary for Sequenom — meaning the company may choose to walk away.
boston.com